AD-89-LX67_1uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=1uM, (5R,8S)-7-[(2S)-2-[[(2S)-2-cyclohexyl-2-[[(3R)-1-ethylpiperidine-3-carbonyl]amino]acetyl]amino]-3,3-dimethylbutanoyl]-N-[(3S)-1-(cyclopropylamino)-1,2-dioxohexan-3-yl]-10,10-dimethyl-7-azadispiro[3.0.45.14]decane-8-carboxamide (Novartis, 25257124)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/25257124
Similar Terms
Downloads & Tools

Genes

10 genes differentially expressed following the AD-89-LX67_1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
MTHFD1 methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase 0.703466
DDX5 DEAD (Asp-Glu-Ala-Asp) box helicase 5 0.288597
CCNE1 cyclin E1 0.286173
PYCR1 pyrroline-5-carboxylate reductase 1 0.286173

decreased expression

Symbol Name Standardized Value
CLPTM1L CLPTM1-like -0.570204
KCTD20 potassium channel tetramerization domain containing 20 -0.269727
HMGN4 high mobility group nucleosomal binding domain 4 -0.243426
SHMT1 serine hydroxymethyltransferase 1 (soluble) -0.241243
TPT1 tumor protein, translationally-controlled 1 -0.241243
CCNC cyclin C -0.204983